The Trump administration's COVID-19 vaccine policy changes mean anyone who is healthy and under 65 will likely have to pay ...

The Trump administration's COVID-19 vaccine policy changes mean anyone who is healthy and under 65 will likely have to pay ...

The FDA’s decision comes at a time when the number of cases of COVID variant NB.1.8.1 have been rising globally, which ...

Two new COVID vaccines were approved for use late last week, and experts continue to encourage seniors to get the booster, but payment issues for ... through free- or low-cost clinics for those ...

Recent changes in government health agency guidelines regarding the COVID-19 vaccine have sparked concerns among healthcare ...

Kennedy this week cited potential safety concerns surrounding Covid vaccine production due to ... Vaxart from invoicing BARDA for the remaining cost of the trials until further notice, though ...

BofA Securities cuts Moderna's price target from $110 to $90 due to vaccine sales concerns. Moderna faces tough competition from Pfizer and declining COVID vaccine ... expects the cost of sales ...

The new policy removes the recommendation for the COVID-19 vaccination during pregnancy. This concerns a number of obstetricians, infectious disease specialists and pediatricians. Pregnant women ...